These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 2361835)
21. Treatment of constitutional delay of growth and adolescence with human growth hormone. Bierich JR Klin Padiatr; 1983; 195(5):309-16. PubMed ID: 6632708 [TBL] [Abstract][Full Text] [Related]
22. Growth deceleration patterns in children with constitutional short stature: an aid to diagnosis. Horner JM; Thorsson AV; Hintz RL Pediatrics; 1978 Oct; 62(4):529-34. PubMed ID: 213764 [TBL] [Abstract][Full Text] [Related]
23. [Effects of clonidine++ administration in children with familial short stature and retarded body growth]. Dorantes-Alvarez L; Coyote-Estrada N; Parra-Paredes S; García-Morales L; Metlich-Medlich B Bol Med Hosp Infant Mex; 1992 Jul; 49(7):422-6. PubMed ID: 1418649 [TBL] [Abstract][Full Text] [Related]
24. [Use of arginine hydrochloride in non-endocrine growth disorders]. Saggese G; Cesaretti G; Ghirri P Minerva Pediatr; 1990 Nov; 42(11):449-59. PubMed ID: 2082171 [TBL] [Abstract][Full Text] [Related]
25. Characteristics of the short children referred to an academic paediatric endocrine clinic in Greece. Papadimitriou A; Douros K; Papadimitriou DT; Kleanthous K; Karapanou O; Fretzayas A J Paediatr Child Health; 2012 Mar; 48(3):263-7. PubMed ID: 22112203 [TBL] [Abstract][Full Text] [Related]
26. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature. Barton JS; Gardineri HM; Cullen S; Hindmarsh PC; Brook CG; Preece MA Clin Endocrinol (Oxf); 1995 Jun; 42(6):619-26. PubMed ID: 7634503 [TBL] [Abstract][Full Text] [Related]
27. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. Soliman AT; elZalabany M; Amer M; Ansari BM J Trop Pediatr; 1999 Feb; 45(1):23-30. PubMed ID: 10191589 [TBL] [Abstract][Full Text] [Related]
28. Adult height predictions for Constitutional Growth Delay, growth hormone treatment for idiopathic short stature and the FDA: are they related? Rapaport R Horm Res; 2006; 65(4):197-9. PubMed ID: 16549933 [No Abstract] [Full Text] [Related]
29. [Are short boys disadvantaged as adults? Follow-up of 77 men with constitutional growth delay and (or) familial short stature]. Holl RW; Schröder H; Heinze E Dtsch Med Wochenschr; 1991 Jun; 116(24):928-34. PubMed ID: 2044460 [TBL] [Abstract][Full Text] [Related]
30. Response to growth hormone treatment and final height after cranial or craniospinal irradiation. Sulmont V; Brauner R; Fontoura M; Rappaport R Acta Paediatr Scand; 1990 May; 79(5):542-9. PubMed ID: 2386044 [TBL] [Abstract][Full Text] [Related]
31. [Causes of short stature in children in relation to their midparental height]. Majcher A; Witkowska-Sędek E; Bielecka-Jasiocha J; Pyrżak B Med Wieku Rozwoj; 2012; 16(2):89-95. PubMed ID: 22971651 [TBL] [Abstract][Full Text] [Related]
32. Clinical diagnoses of children with extremely short stature and their response to growth hormone. Moore KC; Donaldson DL; Ideus PL; Gifford RA; Moore WV J Pediatr; 1993 May; 122(5 Pt 1):687-92. PubMed ID: 8496743 [TBL] [Abstract][Full Text] [Related]
33. Predicting and monitoring of growth in children with short stature during the first year of growth hormone treatment. Mortensen HB; Main K; Michaelsen KF; Kastrup KW; Jłrgensen JT; Skakkebaek NE Acta Paediatr Scand; 1991 Dec; 80(12):1150-7. PubMed ID: 1785287 [TBL] [Abstract][Full Text] [Related]
34. Is priming with sex steroids useful for defining patients who will benefit from GH treatment? De Sanctis V; Soliman AT; Yassin M; Di Maio S Pediatr Endocrinol Rev; 2014 Mar; 11(3):284-7. PubMed ID: 24716393 [TBL] [Abstract][Full Text] [Related]
35. [Differential diagnosis in children with small stature]. Lebl J; Zemková D; Kolousková S; Snajderová M Cas Lek Cesk; 1995 Mar; 134(6):166-9. PubMed ID: 7758066 [TBL] [Abstract][Full Text] [Related]
36. Biosynthetic human growth hormone in the treatment of growth hormone deficiency. Holcombe JH; Conforti PM; Wong AC; Thompson RG; Draper MW Acta Paediatr Scand Suppl; 1990; 367():44-8. PubMed ID: 2220388 [TBL] [Abstract][Full Text] [Related]
37. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty. Hero M; Toiviainen-Salo S; Wickman S; Mäkitie O; Dunkel L J Bone Miner Res; 2010 Jul; 25(7):1536-43. PubMed ID: 20200972 [TBL] [Abstract][Full Text] [Related]
38. Final height in children with growth hormone deficiency. Brämswig JH; Schlösser H; Kiese K Horm Res; 1995; 43(4):126-8. PubMed ID: 7750911 [TBL] [Abstract][Full Text] [Related]
39. Etiologies of short stature in a pediatric endocrine clinic in Southern Thailand. Saengkaew T; McNeil E; Jaruratanasirikul S J Pediatr Endocrinol Metab; 2017 Nov; 30(12):1265-1270. PubMed ID: 29127766 [TBL] [Abstract][Full Text] [Related]
40. Puberty in children with idiopathic growth hormone deficiency on growth hormone treatment: preliminary analysis of the data from the Kabi Pharmacia International Growth Study. Price DA Acta Paediatr Scand Suppl; 1991; 379():117-24; discussion 125. PubMed ID: 1815452 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]